SARTORIUS (SARTF)
(Delayed Data from OTC)
$203.00 USD
+0.09 (0.04%)
Updated Aug 23, 2024 11:52 AM ET
5-Strong Sell of 5 5
D Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
SARTF 203.00 +0.09(0.04%)
Will SARTF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SARTF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SARTF
SARTORIUS (SARTF) Upgraded to Strong Buy: Here's What You Should Know
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
SARTF: What are Zacks experts saying now?
Zacks Private Portfolio Services
SARTORIUS (SARTF) Surges 7.4%: Is This an Indication of Further Gains?
SARTORIUS (SARTF) Q3 Earnings and Revenues Top Estimates
Dynatronics Corporation (DYNT) Reports Q4 Loss, Misses Revenue Estimates
Other News for SARTF
Franklin Growth Fund Q2 2024 Commentary
Invesco International Diversified Fund Q2 2024 Review
Longleaf Partners Fund Q2 2024 Commentary
Danaher Q2: Inventory Overhang, But Low Expectations Limit Downside
RGA Investment Advisors - Sartorius: Purity In The Pure Play Of Bioprocessing